Bioequivalence of mirabegron 50 mg extended release Tablet [Design Issues]

posted by qualityassurance – Jordan, 2022-08-04 17:47 (121 d 21:29 ago) – Posting: # 23202
Views: 647

Dear Ibrahim,

❝ Knowing that I couldn't find an accurate data for intrasubject variability of Mirabegnon.

I know it is very late response but here you can find the literature mentioning the high variability of mirabegron (approximately 33% to 45% for Cmax and 19% to 31% for AUC) AUS PAR.

Hope it may help other forum members.


Complete thread:

UA Flag
 Admin contact
22,428 posts in 4,694 threads, 1,598 registered users;
13 visitors (0 registered, 13 guests [including 9 identified bots]).
Forum time: 14:16 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz